August 11, 2014 / 1:15 PM / 3 years ago

BRIEF-Genmab announces new phase III study of daratumumab

Aug 11 (Reuters) - Genmab A/S : * Announces new phase III study of daratumumab in front line multiple myeloma * Says study expected to start in the first half of 2015 Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below